Clare Market Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,110
| Closed | -$225K | – | 148 |
|
|
2025
Q1 | $225K | Sell |
3,110
-324
| -9% | -$23.5K | 0.06% | 122 |
|
|
2024
Q4 | $254K | Hold |
3,434
| – | – | 0.06% | 127 |
|
|
2024
Q3 | $227K | Buy |
3,434
+700
| +26% | +$46.2K | 0.06% | 141 |
|
|
2024
Q2 | $253K | Buy |
2,734
+124
| +5% | +$11.5K | 0.07% | 122 |
|
|
2024
Q1 | $249K | Buy |
+2,610
| New | +$249K | 0.08% | 130 |
|
|
2023
Q3 | – | Sell |
-2,760
| Closed | -$260K | – | 138 |
|
|
2023
Q2 | $260K | Hold |
2,760
| – | – | 0.1% | 104 |
|
|
2023
Q1 | $228K | Hold |
2,760
| – | – | 0.1% | 106 |
|
|
2022
Q4 | $206K | Hold |
2,760
| – | – | 0.1% | 119 |
|
|
2022
Q3 | $228K | Hold |
2,760
| – | – | 0.1% | 116 |
|
|
2022
Q2 | $262K | Sell |
2,760
-1,200
| -30% | -$114K | 0.11% | 106 |
|
|
2022
Q1 | $466K | Sell |
3,960
-300
| -7% | -$35.3K | 0.15% | 84 |
|
|
2021
Q4 | $552K | Hold |
4,260
| – | – | 0.15% | 75 |
|
|
2021
Q3 | $482K | Hold |
4,260
| – | – | 0.14% | 80 |
|
|
2021
Q2 | $441K | Hold |
4,260
| – | – | 0.14% | 77 |
|
|
2021
Q1 | $356K | Sell |
4,260
-900
| -17% | -$75.3K | 0.13% | 84 |
|
|
2020
Q4 | $471K | Hold |
5,160
| – | – | 0.2% | 60 |
|
|
2020
Q3 | $412K | Hold |
5,160
| – | – | 0.2% | 62 |
|
|
2020
Q2 | $357K | Hold |
5,160
| – | – | 0.21% | 56 |
|
|
2020
Q1 | $324K | Sell |
5,160
-1,050
| -17% | -$66K | 0.27% | 55 |
|
|
2019
Q4 | $483K | Hold |
6,210
| – | – | 0.35% | 55 |
|
|
2019
Q3 | $455K | Buy |
6,210
+405
| +7% | +$29.7K | 0.43% | 46 |
|
|
2019
Q2 | $357K | Sell |
5,805
-600
| -9% | -$36.9K | 0.28% | 67 |
|
|
2019
Q1 | $408K | Buy |
6,405
+1,155
| +22% | +$73.7K | 0.36% | 64 |
|
|
2018
Q4 | $268K | Buy |
+5,250
| New | +$268K | 0.35% | 57 |
|